| Literature DB >> 34083033 |
Reza Heidari1, Mostafa Akbariqomi2, Yazdan Asgari3, Diako Ebrahimi4, Hamid Alinejad-Rokny5.
Abstract
The human transcriptome contains many non-coding RNAs (ncRNAs), which play important roles in gene regulation. Long noncoding RNAs (lncRNAs) are an important class of ncRNAs with lengths between 200 and 200,000 bases. Unlike mRNA, lncRNA lacks protein-coding features, specifically, open-reading frames, and start and stop codons. LncRNAs have been reported to play a role in the pathogenesis and progression of many cancers, including breast cancer (BC), acting as tumor suppressors or oncogenes. In this review, we systematically mined the literature to identify 65 BC-related lncRNAs. We then perform an integrative bioinformatics analysis to identify 14 lncRNAs with a potential regulatory role in BC. The biological function of these 14 lncRNAs, their regulatory mechanisms, and roles in the initiation and progression of BC are discussed in this review. Additionally, we elaborate on the current and future applications of lncRNAs as diagnostic and/or therapeutic biomarkers in BC.Entities:
Keywords: Breast cancer; Causative lncRNAs; Gene prioritization; Gene regulation; Long non-coding RNA; Therapeutic biomarkers
Year: 2021 PMID: 34083033 DOI: 10.1016/j.mrrev.2021.108375
Source DB: PubMed Journal: Mutat Res ISSN: 0027-5107 Impact factor: 2.433